Antigen recognition by CD1d-restricted NKT T cell receptors

Seminars in Immunology
Dale I GodfreyJamie Rossjohn

Abstract

alphabeta T cell receptors (TCRs) have traditionally been viewed as receptors for peptide antigens presented by either Major Histocompatibility Complex (MHC) class I (for CD8 T cells) or MHC class II (for CD4 T cells) antigen-presenting molecules. However, it is now clear that some T cell lineages express TCRs that are specialized for recognition of lipid-based antigens presented by the MHC class I-like CD1 family. Recently, the molecular basis for the TCR recognition of glycolipid antigens presented by CD1d has revealed an evolutionarily conserved-docking mode that is distinct from that of peptide-based recognition. T cells carrying these receptors follow a unique developmental pathway that results not only in unconventional antigen specificity, but also seemingly exaggerated functional capabilities, which makes these cells and their antigens highly attractive targets for immunotherapeutic manipulation.

References

Oct 1, 1995·The Journal of Experimental Medicine·S CardellD Mathis
Apr 17, 2001·The Journal of Experimental Medicine·S H ParkA Bendelac
Jul 9, 2003·The Journal of Experimental Medicine·Dianna Y WuPaul B Chapman
Mar 23, 2004·Annual Review of Immunology·Manfred Brigl, Michael B Brenner
Sep 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ildiko Van RhijnD Branch Moody
Nov 13, 2004·Science·Dapeng ZhouAlbert Bendelac
Mar 26, 2005·Nature·Yuki KinjoMitchell Kronenberg
May 3, 2005·Nature Reviews. Immunology·D Branch MoodyIan A Wilson
Jul 22, 2005·Nature Immunology·Dale I GodfreyJamie Rossjohn
Aug 10, 2005·The Journal of Experimental Medicine·Kamel BenlaghaAlbert Bendelac
Nov 30, 2005·The Journal of Experimental Medicine·Dirk M ZajoncIan A Wilson
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Douglass WuChi-Huey Wong
Jul 28, 2006·Current Opinion in Immunology·Emmanuel Treiner, Olivier Lantz
Aug 22, 2006·Nature Immunology·Yuki KinjoMitchell Kronenberg
Sep 20, 2006·The Journal of Experimental Medicine·Stephan D GadolaVincenzo Cerundolo
Feb 17, 2007·Current Opinion in Immunology·Mitchell Kronenberg, Isaac Engel
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Stefan PorubskyHermann-Josef Gröne
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Anneliese O SpeakFrances M Platt
May 12, 2007·European Journal of Immunology·Jens SchümannGennaro De Libero
Jun 26, 2007·Nature Reviews. Immunology·Dale I Godfrey, Stuart P Berzins
Jul 21, 2007·The Journal of Clinical Investigation·Ramesh C HalderVipin Kumar
Sep 11, 2007·Nature Immunology·James P Scott-BrowneLaurent Gapin
Oct 30, 2007·Trends in Immunology·Masaki Terabe, Jay A Berzofsky
Nov 27, 2007·Nature Reviews. Immunology·Duarte C Barral, Michael B Brenner
Apr 2, 2008·The Journal of Experimental Medicine·Kwok S WunJamie Rossjohn
Jan 14, 2009·The Journal of Experimental Medicine·Julia K ArchboldJamie Rossjohn
Mar 13, 2009·PLoS Biology·Emmanuel MartinOlivier Lantz
Mar 17, 2009·Journal of Proteome Research·Yunsen LiDapeng Zhou

❮ Previous
Next ❯

Citations

Aug 3, 2012·Immunotherapy·Teresa Freire, Eduardo Osinaga
Oct 15, 2010·AIDS Research and Human Retroviruses·Marianne W MureithiThumbi Ndung'u
Jan 5, 2011·Frontiers in Bioscience (Scholar Edition)·Lan Wu, Luc Van Kaer
Mar 9, 2011·The Journal of Experimental Medicine·Yuting MaLaurence Zitvogel
Jun 8, 2011·The Journal of Experimental Medicine·Dale Ian Godfrey, Jamie Rossjohn
Nov 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Onisha PatelDale I Godfrey
Mar 14, 2012·The Journal of Experimental Medicine·Rangsima ReantragoonJames McCluskey
Dec 12, 2012·Immunogenetics·Kentaro TsukamotoKeiichiro Hashimoto
Aug 10, 2010·Acta Pharmacologica Sinica·Jin-quan TanYu-ling He
Feb 8, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Eric Champagne
Aug 2, 2011·Nature Immunology·Daniel G PellicciJamie Rossjohn
Jan 17, 2012·Nature Immunology·Anna M BulekAndrew K Sewell
Jul 12, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Meena S ThakurAmy R Howell
Dec 20, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Brian L AndersonPaul B Savage
Sep 3, 2013·Current Opinion in Immunology·Sidonia B G EckleJames McCluskey
Jan 1, 2014·Protein Science : a Publication of the Protein Society·Mugdha BhatiJamie Rossjohn
Jul 19, 2011·Cellular Immunology·Jesús ReinéMaría J Recio
Oct 26, 2010·Current Opinion in Immunology·Amelia R HofstetterAndrew G Brooks
Aug 19, 2015·Frontiers in Immunology·Elodie Macho-Fernandez, Manfred Brigl
Apr 29, 2015·Mediators of Inflammation·Paula A SuazoPablo A González
Mar 26, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joana M SilvaHelena F Florindo
May 6, 2014·Frontiers in Immunology·Jaime De CalistoCox Terhorst
Jul 6, 2016·Immunogenetics·Shalu Sharma KharkwalSteven A Porcelli
Apr 7, 2018·Frontiers of Medicine·Shasha ZhuLi Bai
Oct 12, 2012·Nature·Lars Kjer-NielsenJames McCluskey
Jul 13, 2013·Nature Communications·Onisha PatelJamie Rossjohn
Apr 21, 2018·European Journal of Immunology·Dominic Paquin-ProulxNiklas K Björkström
Aug 23, 2012·Nature Immunology·Erin J Adams, Adrienne M Luoma
Feb 9, 2010·Nature Immunology·Dale I GodfreyAlan G Baxter
Nov 17, 2012·Nature Reviews. Immunology·Jamie RossjohnDale I Godfrey
Jul 10, 2013·Cellular and Molecular Life Sciences : CMLS·M RakhshandehrooM Boes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.